Murray Passo to Infant
This is a "connection" page, showing publications Murray Passo has written about Infant.
Connection Strength
0.106
-
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in?Children With Polyarticular Forms of Juvenile Idiopathic?Arthritis With Clinically Inactive Disease. Arthritis Rheumatol. 2018 09; 70(9):1508-1518.
Score: 0.024
-
Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2013 May; 65(5):745-52.
Score: 0.017
-
Incomplete Kawasaki disease with facial nerve paralysis and coronary artery involvement. Pediatr Infect Dis J. 1988 Apr; 7(4):301-2.
Score: 0.012
-
Arthritis associated with inflammatory bowel disease in children. Relationship of joint disease to activity and severity of bowel lesion. Dig Dis Sci. 1986 May; 31(5):492-7.
Score: 0.010
-
What more can we learn from muscle histopathology in children with dermatomyositis/polymyositis? Clin Exp Rheumatol. 2006 May-Jun; 24(3):333-43.
Score: 0.010
-
Feasibility and construct validity of the parent willingness-to-pay technique for children with juvenile idiopathic arthritis. Arthritis Rheum. 2004 Dec 15; 51(6):899-908.
Score: 0.009
-
Arthritis in childhood. J Indiana State Med Assoc. 1981 Sep; 74(9):559-64.
Score: 0.007
-
Age-specific effects of juvenile rheumatoid arthritis-associated HLA alleles. Arthritis Rheum. 1999 Sep; 42(9):1843-53.
Score: 0.006
-
Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease. J Rheumatol. 1998 Jul; 25(7):1388-98.
Score: 0.006
-
Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric Rheumatology Collaborative Study Group. J Rheumatol. 1994 Dec; 21(12):2353-8.
Score: 0.005